A new study shows the first known evidence of Alzheimer's in living people that appears to have been acquired as a result of previous medical treatments.
Scientists have restored the nerve cell connections in the brain that are destroyed by Alzheimer's, while others have found a connection between the health of blood vessels and development of the disease.
Scientists have found that a subset of CD8<sup>+</sup> T cells in the brain lessens the activation of microglia and limits disease pathology in a model of Alzheimer's disease.
The phase 3 drug trial from Eli Lilly and Company indicated significantly slowed cognitive and functional decline in people with early symptomatic Alzheimer's.